SCHEMBL3467425

SCHEMBL3467425

N#Cc1cccc(-c2ccc(CCC(CC=Cc3ccc(Br)cc3)C(=O)O)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.54
MMP13 P45452 2/20 0.54
GRIK1 P39086 5/20 0.46
GRIK2 Q13002 5/20 0.46
MME P08473 2/20 0.41
P4HB P07237 1/20 0.40
FOLH1 Q04609 1/20 0.39
XDH P47989 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
ADAMTS4 O75173 1/20 0.38
FFAR1 O14842 1/20 0.37
MCHR1 Q99705 1/20 0.37
MMP2 P08253 2/20 0.36
MMP3 P08254 2/20 0.36
CTSC P53634 1/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466777 1.00 MMP12 (0.54) MMP12MMP13GRIK1GRIK2MME
SCHEMBL7923446 0.93 MMP12 (0.57) MMP12MMP13GRIK1GRIK2MME
SCHEMBL3467200 0.86 MMP12 (0.60) MMP12MMP13MMEFOLH1XDH
SCHEMBL7924636 0.79 MMP12 (0.65) MMP12MMP13MMEFOLH1XDH
SCHEMBL7928277 0.78 MMP12 (0.64) MMP12MMP13GRIK1MMEFOLH1
SCHEMBL7932591 0.77 MMP12 (0.63) MMP12MMP13GRIK1MMEFOLH1
SCHEMBL3468280 0.76 MMP12 (0.53) MMP12MMP13MMEFOLH1ADAMTS4
SCHEMBL3465875 0.72 MMP12 (0.65) MMP12MMP13MMEXDHSLC22A12
SCHEMBL1857647 0.72 GRIK1 (0.60) GRIK1GRIK2
SCHEMBL1857645 0.72 GRIK1 (0.60) GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed